Camber Launches Generic Sustiva®
Piscataway, NJ, May 2, 2018– Camber Pharmaceuticals is pleased to announce the addition of Efavirenz Tablets to our growing portfolio of products.
Efavirenz tablets are the generic version of Sustiva®. Sustiva is used to treat HIV.
Efavirenz tablets are available in 600mg 30ct bottle.
Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the market and provide a level of excellence in service, supply and affordability.
If you would like more information about this topic, please contact Kirk Hessels at 732.529.0430 or email at [email protected].
Recent articles
- Camber Launches Temozolomide Capsules, USP
- Camber Launches Eltrombopag Tablets & Oral Suspension
- Camber Launches Eslicarbazepine Acetate Tablets
- Camber Launches Phenylephrine Hydrochloride Injection, USP
- Camber Launches Chlorzoxazone Tablets, USP
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year